Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
3
5
1
0
ROCHE HOLDING AG
Share · CH0012032048 · 855167 (XSWX)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ROCHE HOLDING AG
Analyst Grade Summary
No Price
27.04.2026 19:44
Share Float & Liquidity
Free Float 90,68 %
Shares Float 721,79 M
Shares Outstanding 796 M
Invested Funds
The following funds have invested in ROCHE HOLDING AG:
Fund | Vol. in million 7.304,78 | Percentage (%) 16,73 % |
Fund | Vol. in million 26.565,54 | Percentage (%) 9,02 % |
Fund | Vol. in million 224,78 | Percentage (%) 5,23 % |
Fund | Vol. in million 5.614,35 | Percentage (%) 5,18 % |
Fund | Vol. in million 2.022,29 | Percentage (%) 4,33 % |
Company Profile for ROCHE HOLDING AG Share
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Company Data
Name ROCHE HOLDING AG
Company Roche Holding AG
Website
https://www.roche.com
Primary Exchange 
SIX
SIX
WKN 855167
ISIN CH0012032048
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Thomas Schinecker
Market Capitalization 257 Mrd.
Country Switzerland
Currency CHF
Employees 103,2 T
Address Konzern Hauptsitz, 4070 Basel
IPO Date 1995-08-03
Dividends from 'ROCHE HOLDING AG'
| Ex-Date | Dividend per Share |
|---|---|
| 12.03.2026 | 9,80 CHF |
| 27.03.2025 | 9,70 CHF |
| 28.03.2025 | 10,99 USD |
| 27.03.2025 | 10,97 USD |
| 14.03.2024 | 9,60 CHF |
| 14.03.2024 | 10,93 USD |
| 16.03.2023 | 9,50 CHF |
| 16.03.2023 | 10,18 USD |
| 17.03.2022 | 9,30 CHF |
| 17.03.2022 | 9,89 USD |
Stock Splits
| Date | Split |
|---|---|
| 04.05.2001 | 100:1 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | RHHVF |
| Düsseldorf | 120348.DUSB |
| Frankfurt | RHO5.F |
| Hamburg | 120348.HAMB |
| Quotrix | 120348.DUSD |
| SIX | ROG.SW |
More Shares
Investors who hold ROCHE HOLDING AG also have the following shares in their portfolio:
